Old Web
English
Sign In
Acemap
>
Paper
>
MA03.03 NBTXR3 Activated by SBRT Combined with Nivolumab or Pembrolizumab in Patients With Advanced Cancers: Phase I Trial
MA03.03 NBTXR3 Activated by SBRT Combined with Nivolumab or Pembrolizumab in Patients With Advanced Cancers: Phase I Trial
2021
Colette J. Shen
J.M. Frakes
Jiaxin Niu
Ari Rosenberg
Jared Weiss
Jimmy J. Caudell
K. Jameson
P. Said
T. Y. Seiwert
Keywords:
Oncology
Pembrolizumab
Medicine
in patient
Internal medicine
Nivolumab
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]